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Hemodynamic forces modulate the size and 
thickness of blood vessels through structural   
alterations of the vessel wall termed vascular   
remodeling (Langille, 1996). Increased blood 
flow leads to vessel enlargement, whereas de-
creased blood flow leads to vessel shrinkage 
(Kamiya and Togawa, 1980; Langille et al., 
1989). Proportional changes in medial mass 
under these circumstances keep wall thickness 
constant. In contrast, increased blood pressure 
results in thickened vessel walls (Baumbach and 
Heistad, 1989). These adaptive responses of the 
vessel wall to hemodynamic stresses are critical 
in arterial development and growth as well as 
in arterial disease (Hong et al., 2002; le Noble 
et al., 2004). The process of vascular remodel-
ing requires reorganization of the cellular and 
extracellular matrix components of the vessel   
wall. Cellular turnover involves smooth muscle 
cell proliferation, apoptosis, and migration (Rudic   
et al., 1998, 2000; Korshunov and Berk, 2003). 
In addition, extracellular matrix turnover de-
pends on degradation by proteinase enzymes, 
e.g., matrix metalloproteinases (MMPs), syn-
thesis by smooth muscle cells, and cross-linking 
by enzymes with transglutaminase activity, such 
as transglutaminase 2 (TGM2) and factor XIII A 
subunit (FXIIIA; Bassiouny et al., 1998; Galis   
et al., 2002; Bakker et al., 2006).
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Sustained changes in blood flow modulate the size of conduit arteries through structural 
alterations of the vessel wall that are dependent on the transient accumulation and activa-
tion of perivascular macrophages. The leukocytic infiltrate appears to be confined to the 
adventitia, is responsible for medial remodeling, and resolves once hemodynamic stresses 
have normalized without obvious intimal changes. We report that inward remodeling of  
the mouse common carotid artery after ligation of the ipsilateral external carotid artery  
is dependent on the chemokine receptor CXCR3. Wild-type myeloid cells restored flow-
mediated vascular remodeling in CXCR3-deficient recipients, adventitia-infiltrating macro-
phages of Gr1low resident phenotype expressed CXCR3, the perivascular accumulation of 
macrophages was dependent on CXCR3 signaling, and the CXCR3 ligand IP-10 was sufficient 
to recruit monocytes to the adventitia. CXCR3 also contributed to selective features of 
macrophage activation required for extracellular matrix turnover, such as production of the 
transglutaminase factor XIII A subunit. Human adventitial macrophages displaying a CD14+/
CD16+ resident phenotype, but not circulating monocytes, expressed CXCR3, and such cells 
were more frequent at sites of disturbed flow. Our observations reveal a CXCR3-dependent 
accumulation and activation of perivascular macrophages as a necessary step in homeostatic 
arterial remodeling triggered by hemodynamic stress in mice and possibly in humans as well.
© 2010 Zhou et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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and glucocorticoids, generate variant polarized M3 macro-
phages with primary immunoregulatory roles as a result of 
IL-10 production.
Chemokine receptor expression contributes to the pref-
erential trafficking of various monocyte subsets to tissues 
under physiological and pathological conditions. Longer- 
lived resident monocytes are CCR2 and CX3CR1high, 
whereas short-lived inflammatory monocytes are CCR2+ and   
CX3CR1low (Geissmann et al., 2003). Among other homing   
receptors, monocytes are dependent on CCR2, CCR5, and 
CX3CR1 to gain entry into atherosclerotic plaques of the 
artery wall (Tacke et al., 2007; Combadière et al., 2008; 
Saederup et al., 2008) and CX3CR1 is also necessary for 
monocyte trafficking to the intima of aged nonatheroscle-
rotic aortas (Liu et al., 2008). Homing requirements or re-
tention  signals  for  monocytes  to  the  arterial  adventitia   
have not been described. CXCR3, the receptor for IP-10 
(IFN-–induced protein of 10 kD; also designated CXCL10) 
and  monokine  induced  by  IFN-  (Mig;  also  designated 
CXCL9), is well characterized as a marker of activated and 
memory T cells. However, it has been known since the early 
descriptions  of  these  molecules  that  CXCR3  is  also  ex-
pressed by monocytes/macrophages and that IP-10 will pro-
mote their recruitment (Luster and Leder, 1993; Taub et al., 
1993; Luster et al., 1995). Finally, certain chemokines, such 
as CCR5 ligands, also contribute to macrophage activation 
(Zhou et al., 1998), although CXCR3 ligands have not pre-
viously been shown to play such a role. In this paper, we   
explain that the expression of CXCR3 by macrophages is 
necessary for flow-mediated inward vascular remodeling and 
that CXCR3 signaling contributes both to macrophage   
accumulation in the adventitia and to a limited but unique 
pattern of macrophage activation in response to altered he-
modynamic stresses.
Flow-mediated vascular remodeling was believed to be 
an intrinsic property of the vessel wall. Recent work has 
challenged this paradigm with the observation that perivas-
cular macrophages are necessary for enlargement or shrink-
age of rodent carotid and mesenteric arteries as a result of 
increased  or  decreased  blood  flow,  respectively  (Bakker   
et al., 2008; Tang et al., 2008; Nuki et al., 2009). Rapid   
superoxide-initiated cytokine and chemokine production by 
vessel wall cells is followed by transient accumulation and 
activation of macrophages. Both phases are dependent on the 
expression of the adaptor molecule myeloid differentiation 
protein 88 (MyD88) and both are required for changes in 
vessel size (Tang et al., 2008). However, previous investiga-
tions  have  not  identified  specific  inflammatory  mediators 
with nonredundant roles in animal models of flow-mediated 
vascular remodeling.
Macrophages display great plasticity and are involved in 
host defense as well as homeostatic processes, such as wound 
healing and tissue remodeling (Mosser and Edwards, 2008). 
In keeping with multiple functions, macrophages and their 
monocyte precursors are heterogeneous (Gordon and Taylor, 
2005). Further phenotypic polarization with distinct func-
tional programs can be induced in macrophages by environ-
mental  stimuli  that  are  generated  after  infection  or  tissue 
injury (Gordon and Taylor, 2005; Martinez, et al., 2008; 
Mosser and Edwards, 2008). Classical activation by prototyp-
ical stimuli of IFN- or LPS gives rise to M1 polarized mac-
rophages with potent microbicidal and proinflammatory 
properties,  including  expression  of  inducible  nitric  oxide 
synthase (iNOS) and TNF production. In contrast, alterna-
tive activation by IL-4 or IL-13 gives rise to M2 polarized 
macrophages with enhanced capacity for tissue repair, for   
example, through secretion of MMPs and FXIIIA. A variety 
of other signals, such as immune complexes, IL-10, TGF-, 
Figure 1.  CXCR3 is necessary for flow-mediated inward vascular remodeling. (a) The left external carotid artery was ligated, and morphometric 
assessment at the midpoint of the left and right common carotid arteries was performed after 2 wk. (b) Representative photomicrographs of hematoxylin 
and eosin–stained transverse sections of right (unligated side) and left (ligated side) common carotid arteries in WT and CXCR3/ mice. Bar, 200 µm.  
The vessel walls at twofold higher magnification are depicted in the insets. (c and d) Common carotid artery size (external elastic lamina or EEL perimeter; c) 
and wall (medial) thickness (d) was determined by image analysis software in WT, CXCR3/, IL-1R/, IL-6/, TNFR1/R2/, and iNOS/ mice. Data are 
means ± SE (n = 9–10 pooled from six operative sessions). *, P < 0.05; **, P < 0.001, KO versus WT.JEM VOL. 207, August 30, 2010 
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tracked to the remodeling vessel wall in WT and CXCR3/ 
hosts (Fig. S1). i.v. administration of bone marrow myeloid 
cells from CXCR3/ donors to CXCR3/ recipients did 
not alter the abnormal response of absent inward remodeling 
and aberrant medial thickening in common carotid arteries   
RESULTS
CXCR3 is necessary for flow-mediated inward  
vascular remodeling
To gain mechanistic insight into our previous observation that 
the expression of IP-10, Mig, IL-1, IL-6, TNF, and iNOS is 
induced within conduit arteries in response to outflow reduc-
tion (Tang et al., 2008), we investigated if any of these proin-
flammatory factors are necessary for flow-mediated vascular 
remodeling. To test the role of IP-10 and Mig, we compared 
adaptive vascular remodeling in WT versus CXCR3-deficient 
(CXCR3/) mice by measuring common carotid artery size 
and wall thickness at 2 wk after left external carotid artery   
ligation (Fig. 1 a). In WT mice, the left common carotid ar-
teries displayed a 10–15% reduction in external perimeter, 
whereas medial thickness remained unchanged compared 
with the right common carotid arteries from the unligated 
side (Fig. 1, b–d). Strikingly, left common carotid arteries in 
CXCR3/ mice did not inwardly remodel but responded by 
medial thickening instead. In contrast, mice with a deficiency 
of other proinflammatory factors induced by decreased blood 
flow (or with a deficiency of their receptors), such as IL-1R, 
IL-6, TNFR1/R2, and iNOS, showed similar vascular remod-
eling responses to that in WT mice, except for modestly less 
vessel shrinkage in IL-6/ mice (Fig. 1 d). These results sug-
gest a nonredundant role for CXCR3 ligands, such as IP-10 
and Mig, in adaptive vascular remodeling that is not a general 
feature of other proinflammatory factors induced by perturba-
tions in blood flow.
Adoptive transfer of WT myeloid cells to CXCR3/ 
recipients restores flow-mediated inward vascular 
remodeling responses
Although CXCR3 is known to be expressed by both mouse 
T cells and macrophages (Luster and Leder, 1993; Taub et al., 
1993; Luster et al., 1995), we have previously shown that ves-
sel shrinkage in response to decreased blood flow is dependent 
on macrophages and not T cells (Tang et al., 2008). There-
fore, we tested if monocytes from WT mice were sufficient   
to restore flow-mediated vascular remodeling in CXCR3/  
recipients. We were unable to achieve detectable adoptive 
transfer of blood monocytes, likely because of limited yield 
(Fig. S1). Larger numbers of bone marrow myeloid cells could 
be obtained after density centrifugation and immunomagnetic 
bead depletion of lymphoid cells and erythrocytes. The en-
riched cell population from WT mice was 95% positive for 
the myeloid cell marker CD11b and 60% positive for CXCR3, 
albeit at relatively low levels (Fig. 2 a). CXCR3 expression by 
the selected bone marrow cells was limited to Ly-6C+ mono-
cytes (Fleming et al., 1993) and was not detectable on small 
numbers of contaminating Ly-6G+ granulocytes or CD42d+ 
platelets (Fig. S2). Adoptively transferred bone marrow my-
eloid cells persisted in the circulation of WT and CXCR3/ 
hosts for at least 3 d (Fig. S1), which was the peak period of 
perivascular  macrophage  recruitment  in  this  model  (Tang   
et al., 2008). We also used polymorphic determinants to the 
CD45 leukocyte common marker to confirm that donor cells 
Figure 2.  WT myeloid cells restore flow-mediated inward vascular 
remodeling in CXCR3/ mice. (a) Bone marrow myeloid cells were 
negatively selected using density centrifugation and immunomagnetic 
beads and analyzed by FACS for CD11b and CXCR3 expression. (b) Repre-
sentative photomicrographs of hematoxylin and eosin–stained transverse 
sections of the right (unligated side) and left (ligated side) common ca-
rotid arteries from CXCR3/ animals that received 2.7 × 106 bone mar-
row monocytes i.v. from CXCR3/ mice or from WT mice 12 h before 
ligation of the left external carotid artery. Bar, 200 µm. The vessel walls at 
twofold higher magnification are depicted in the insets. (c) Common ca-
rotid artery size (external elastic lamina or EEL perimeter) and wall (me-
dial) thickness was determined by image analysis software in these 
animals. Data are means ± SE (n = 9–10 pooled from two operative ses-
sions). *, P < 0.05; **, P < 0.001, WT to CXCR3/ versus CXCR3/ to 
CXCR3/. (d) CXCR3 transcripts were quantified by real-time PCR and 
normalized to GAPDH from left and right common carotid arteries of 
CXCR3/ mice at 3 d after adoptive transfer of WT bone marrow myeloid 
cells and left external carotid artery ligation. Data are means ± SE (n = 8 
from one operative session). **, P < 0.001, left versus right.1954 Role of CXCR3 in adaptive vascular remodeling | Zhou et al.
signals from excessive debris in enzyme-digested artery prep-
arations). The majority of adventitial macrophages, defined as 
CD11b-selected F4/80+ cells, expressed CXCR3 as did cir-
culating monocytes with the same surface markers (Fig. 3,   
e and f). The spleen and bone marrow contained fewer such 
cells, although these differences did not achieve statistical sig-
nificance. Thus, CXCR3 expression is widely detected on 
diverse populations of F4/80+ monocytes/macrophages.
Increased CXCR3 expression by Gr1low perivascular macrophages
We further assessed the relative expression of CXCR3 by 
various populations of monocytes and macrophages defined 
by the Gr1 marker using flow cytometric analysis. Antibodies 
to the Gr1 determinant react with both Ly-6C (expressed by 
monocytes and granulocytes) and Ly-6G (expressed by gran-
ulocytes but not monocytes), and low versus high expression 
of Gr1 characterizes distinct subpopulations of mouse blood 
monocytes and plaque-infiltrating macrophages (Sunderkötter 
et al., 2004; Tacke et al., 2007). Two separate groups of 
CD11b-selected F4/80+ blood monocytes were identified by 
low versus high Gr1 expression with modest surface expres-
sion of CXCR3 (Fig. 4 a, R1 and R2). In contrast, CD11b-
selected F4/80 Gr1high cells had little CXCR3 expression 
(Fig. 4 a, R3). Both the Gr1high cell populations (R2 and R3) 
expressed Ly-6C, but not Ly-6G, identifying them as mono-
cytes (Fig. S3). The F4/80 population (R3) likely represents 
monocytes recently emigrated from bone marrow or spleen. 
Artery-infiltrating macrophages had increased F4/80 expres-
sion, far fewer Gr1high cells, more frequent Gr1low cells, and 
10-fold greater CXCR3 expression as compared with blood 
monocytes (Fig. 4 b). CD11b-selected F4/80 Gr1+ cells 
were not detected within the vessel wall. Forward versus side 
scatter profiles revealed two populations of small and large 
artery-associated macrophages with overlapping expression 
patterns and less than twofold differences for F4/80, Gr1, and 
after external carotid artery ligation (Fig. 2, b and c), which 
was similar to that seen in CXCR3/ mice without adoptive 
transfer of cells. In contrast, adoptive transfer of bone marrow 
myeloid  cells  from  WT  donors  to  CXCR3/  recipients   
restored the phenotype of inward remodeling without me-
dial thickening in response to outflow reduction, as in WT 
mice. CXCR3 was detected in the ligated, but not unli-
gated, carotid arteries of CXCR3/ recipients of WT my-
eloid  cells  (Fig.  2  d),  confirming  selective  homing  of  the 
adoptively transferred cells to the remodeling vessel. These 
experiments  implicate  monocytes/macrophages  as  relevant 
cell  types  involved  in  CXCR3-dependent  flow-mediated 
vascular remodeling.
CXCR3 is expressed in the adventitia of remodeling arteries
Because CXCR3 is necessary for vascular remodeling, we 
examined for its expression within the vessel wall of WT ani-
mals. Quantitative PCR analysis showed a time-dependent 
increase in CXCR3 transcripts within common carotid arter-
ies after external carotid artery ligation, with peak expression 
at 3 d (Fig. 3 a). Immunohistochemical analysis verified the 
presence of CXCR3 and one of its ligands, IP-10, within the 
adventitia of remodeling arteries (Fig. 3, b and c). These re-
sults mirrored our previous finding that macrophages consti-
tute the major population of artery-associated leukocytes in 
this model, with peak accumulation between 3 and 7 d after 
outflow reduction (Tang et al., 2008), and the expression   
of CXCR3 largely coincided with that of the macrophage 
marker F4/80 by immunofluorescence imaging (Fig. 3 d). 
However, not all F4/80+ cells expressed CXCR3 and certain 
CXCR3+ cells did not express F4/80. We quantified the ex-
pression of these markers by flow cytometric analysis of   
myeloid cells selected by CD11b antibody-coated magnetic 
beads from various sites (initial selection of relevant cells with 
immunomagnetic beads was necessary to avoid confounding 
Figure 3.  CXCR3 is expressed by artery-
associated macrophages. (a) CXCR3 tran-
scripts were quantified by real-time PCR and 
normalized to GAPDH from left and right 
common carotid arteries of WT mice at 6 h  
(n = 10), 3 d (n = 9), and 10 d (n = 4) after left 
external carotid artery ligation. Data are 
means ± SE (pooled from three operative  
sessions). *, P < 0.05, left versus right.  
(b and c) CXCR3 (b) and IP-10 (c) immuno-
histochemical reactivity (brown, arrowheads) in 
left common carotid arteries at 3 d after outflow 
reduction. Bars, 100 µm. Absent immunostain-
ing in right common carotid arteries is shown 
in insets. (d) F4/80 (green) and CXCR3 (red) 
immunofluorescence signal in left common 
carotid artery at 3 d after outflow reduction. 
The overlapping dual signal (orange) is marked 
by arrowheads. Bar, 50 µm. Irrelevant isotype-
matched antibody reactivity is depicted in the inset. (e) Cells were isolated from common carotid arteries at 3 d after partial outflow ligation using CD11b 
antibody-coated magnetic beads and analyzed by flow cytometry for CXCR3 and F4/80 expression. (f) CXCR3 expression by common carotid artery, blood, 
spleen, and bone marrow (BM) CD11b-selected F4/80-expressing cells. Data are means ± SE (n = 4 pooled from four independent experiments).JEM VOL. 207, August 30, 2010 
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Figure 4.  CXCR3 expression by Gr1-defined populations of blood 
monocytes and artery macrophages. Cells were isolated from blood  
(a) or left common carotid arteries (pooled from 22 mice; b) at 3 d after 
partial outflow ligation using CD11b antibody-coated magnetic beads and 
analyzed by flow cytometry for control IgG reactivity or F4/80 and Gr1 
expression, which delineated three discrete populations of myeloid cells. 
Their frequency is shown, calculated as the percentage of total cells. The 
Gr1-defined cell populations were further analyzed for CXCR3 expression 
(open histograms) or irrelevant isotype-matched antibody reactivity 
(shaded histograms), and the mean fluorescence intensity is shown. Data 
are representative of three independent experiments.
CXCR3 (Fig. S4). The flow cytometry data indicate that a 
unique subtype of macrophage accumulates around the vessel 
wall in response to decreased blood flow, and a distinguishing 
feature of the remodeling-associated macrophage is the higher 
expression of CXCR3.
Perivascular accumulation of macrophages after decreased 
blood flow is CXCR3 dependent
Having shown that macrophages associated with remodeling 
arteries express CXCR3, we next investigated if CXCR3 sig-
naling contributes to monocyte trafficking to the vessel wall. 
The early induction of IP-10 and Mig transcripts in vascular 
cells at 6 h after external carotid artery ligation did not differ 
between WT and CXCR3/ mice (Fig. 5 a). However, the 
accumulation of F4/80 transcripts was less in common carotid 
arteries from CXCR3/ mice compared with WT mice at   
3 d (Fig. 5 b) and 7 d (not depicted). We verified decreased 
recruitment and/or retention of macrophages in CXCR3/ 
animals by counting F4/80+ cells in artery sections (Fig. 5,   
c and d). To determine if CXCR3 signaling was sufficient for 
monocyte infiltration of the vessel wall independent of lym-
phocyte trafficking, we applied IP-10 to the tissues surround-
ing the common carotid artery of RAG1/ mice deficient in 
T and B cells. This resulted in infiltration of F4/80+ cells to 
Figure 5.  CXCR3 is necessary and sufficient for perivascular macro-
phage accumulation. (a and b) Transcripts for IP-10 and Mig at 6 h  
(a) and F4/80 at 3 d (b) were quantified by real-time PCR and normalized to 
GAPDH from right and left common carotid arteries of WT and CXCR3/ 
mice after left external carotid artery ligation (n = 8–10 pooled from four 
operative sessions). (c) The number of F4/80+ cells per vessel cross section  
(x-sec) were counted from immunohistochemical analyses of common ca-
rotid arteries at 3 d after outflow reduction (n = 8 pooled from two operative 
sessions). (d) Representative photomicrographs from c are shown. Bar, 100 µm. 
Irrelevant isotype-matched antibody reactivity is depicted in the inset.  
(e) F4/80+ cells per vessel cross section were also counted from common carotid  
arteries infiltrated with saline or IP-10 at 300 ng/µl for 3 d in RAG1/ mice 
(n = 6 pooled from two operative sessions). Bar, 100 µm. Data are means ± SE. 
*, P < 0.05, left versus right, CXCR3/ versus WT, or IP-10 versus saline.
the adventitia of IP-10–treated, but not contralateral, vehicle-
treated vessels at 3 d (Fig. 5 e). Macrophages were not de-
tected within the media or intima of the arteries similar to the 1956 Role of CXCR3 in adaptive vascular remodeling | Zhou et al.
Figure 6.  Production of macrophage mediators of vascular inflammation and remodeling after decreased flow is CXCR3 dependent.  
(a) Transcripts for iNOS and TNF were quantified by real-time PCR and normalized to GAPDH from right and left common carotid arteries of WT and CXCR3/ 
mice at 3 d after left external carotid artery ligation (n = 9 pooled from two operative sessions). (b) Transcripts for MMP9, MMP2, and FXIIIA in left com-
mon carotid arteries of WT mice at 0 h, 6 h, 3 d, and 7 d after operation (n = 9–10 pooled from four operative sessions). (c) Immunofluorescence analyses 
of MMP9, MMP2, and FXIIIA expression in common carotid arteries at 3 d after outflow reduction, orientation with lumen below and adventitia above. 
Arrowheads mark immunofluorescence signal. Bar, 50 µm. Irrelevant isotype-matched antibody reactivity is depicted in the insets. (d) Collagenase and 
transglutaminase (TGase) activity in lysates of common carotid arteries at 3 d after outflow reduction. Standards of purified MMP9 and MMP2 indicate 
pro- and active MMP bands in gel zymogram. n = 3 from one operative session in transglutaminase assay. (e) In situ collagenase and transglutaminase 
activity in common carotid arteries at 3 d after outflow reduction. Enzyme activity is colored green and is marked by arrowheads. Bar, 50 µm. (f) Transcripts JEM VOL. 207, August 30, 2010 
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limited distribution noted after blood flow reduction. These 
results demonstrate that CXCR3 was necessary and sufficient 
for perivascular macrophage accumulation.
Production of macrophage mediators of vascular remodeling 
after decreased blood flow is CXCR3 dependent
We further investigated if CXCR3 signaling was required for 
the production of macrophage mediators of vascular inflam-
mation and remodeling. iNOS, but not TNF, transcripts were 
diminished in common carotid arteries from CXCR3/ mice 
compared with WT mice at 3 d after outflow reduction   
(Fig. 6 a), which was previously documented as the time of 
peak expression for these inflammatory mediators in this   
experimental model (Tang et al., 2008). Because our results 
showed that neither iNOS nor TNF played nonredundant 
roles in inward vascular remodeling (Fig. 1 d), we also assessed 
the expression of other effector molecules that have been as-
sociated with extracellular matrix turnover and flow-mediated 
vascular remodeling, such as the proteinases, MMP2 and 
MMP9, and the transglutaminase FXIIIA (Bassiouny et al., 
1998; Galis et al., 2002; Bakker et al., 2006). In common ca-
rotid arteries of WT mice, MMP9 transcripts that were unde-
tectable preoperatively were induced early between 6 h and   
3 d after external carotid artery ligation, whereas the basal   
expression  of  MMP2  and  FXIIIA  transcripts  was  up- 
regulated later between 3 and 7 d after operation (Fig. 6 b).   
for MMP9 at 6 h, MMP2 at 7 d, and FXIIIA at 7 d after operation in common carotid arteries of WT and CXCR3/ mice (n = 7–10 pooled from two opera-
tive sessions). Data are means ± SE. *, P < 0.05; **, P < 0.01, left versus right, CXCR3/ versus WT, or after ligation versus 0 h.
 
Figure 7.  FXIIIA production is limited to CXCR3-expressing macrophages and FXIIIA is frequently coexpressed with MMP9 in situ. (a) Perivascular 
macrophages were isolated with anti-CD11b–coated magnetic beads from common carotid arteries 3 d after ipsilateral external carotid artery ligation. 
CXCR3 and CXCR3+ F4/80-expressing macrophages were sorted by flow cytometry, RNA was extracted from an equal number of cells, and FXIIIA, MMP9, 
and TNF transcripts were measured by real-time PCR (n = 5–7 pooled from three independent experiments). Data are means ± SE. **, P < 0.001, CXCR3+ 
versus CXCR3. (b) Alternatively, CD11b-selected CD3/B220/CD11c adventitial macrophages were isolated by immunomagnetic beads and flow cytom-
etry from 18 remodeling arteries (generated in one operative session) at 3 d after operation, treated with PMA and ionomycin for 5 h, cytospins were  
prepared, and the expression of FXIIIA and MMP9 was analyzed by immunofluorescence (IF) microscopy and image analysis software from 134 images.  
(c) Representative photomicrographs are shown of predominantly MMP9-expressing (i and iv), predominantly FXIIIA-expressing (ii and v), and dual FXIIIA-
MMP9-expressing (iii and vi) small (top) and large (bottom) macrophages. (d) Similar analysis was performed on cytospins of untreated adventitial macro-
phages. Bar, 15 µm. Irrelevant isotype-matched antibody reactivity is depicted in the insets. Data are representative of two independent experiments.1958 Role of CXCR3 in adaptive vascular remodeling | Zhou et al.
which increased CXCR3 expression (unpublished data), be-
fore treatment with various proinflammatory agents. IP-10 
selectively induced the expression of FXIIIA transcripts, 
whereas a prototypical alternative activator of macrophages, 
IL-4, and a prototypical classical activator of macrophages, 
LPS, induced the expression of MMP9 and TNF transcripts, 
respectively (Fig. 8 a). We verified the IP-10–mediated up-
regulation of FXIIIA transcripts with additional dose-response 
experiments, as well as induction of FXIIIA protein by West-
ern blotting which was associated with increased transgluta-
minase activity (Fig. 8 b). Similarly, FXIIIA was induced by 
IP-10 in blood monocytes independent of the need for   
M-CSF–mediated differentiation (Fig. S5). In contrast, IL-4 and 
LPS diminished the basal expression of FXIIIA by bone 
marrow–differentiated macrophages and inhibited the effects of 
IP-10 but not vice versa (Fig. 8 c). Further analyses were per-
formed for other markers of alternative and classical macro-
phage activation. As expected, IL-4 up-regulated arginase I, 
Ym1, and Fizz1 transcripts (Nair et al., 2003), whereas LPS 
induced iNOS transcripts. IP-10 at 300 ng/ml for 72 h did 
not significantly affect the expression of any of these mole-
cules (Table S1). Unlike IL-4 or LPS, IP-10 did not modulate 
the production of the immunoregulatory cytokine IL-10.   
Additionally, the expression of TGM2, an alternative source 
of transglutaminase activity in remodeling vessels, was not 
modulated by IP-10 but was inhibited by IL-4 and LPS. We 
verified that the IP-10–mediated induction of FXIIIA was 
CXCR3 dependent, which is in contrast to the qualitatively 
similar effects of IL-4 and LPS on WT cells in the presence of 
CXCR3 blocking antibodies or on CXCR3/ cells (Fig. 8 d). 
Together, these in vitro data demonstrate that CXCR3 sig-
naling contributes to selective and unique features of macro-
phage activation in the absence of other cell types.
Human perivascular macrophages express CXCR3
To determine if our findings in mouse models may be of rel-
evance in human biology, we examined the phenotype of 
perivascular macrophages in clinical specimens. CD11b+ cells 
were selected by magnetic beads from blood and aortic ad-
ventitia and analyzed by flow cytometry. CXCR3 was ex-
pressed by a distinct population of CD11b-selected CD14+ 
adventitial macrophages but not by circulating monocytes 
(Fig. 9 a). CD11b+/CD14+/CXCR3+ perivascular cells did 
not express lymphocyte or neutrophil markers and were 
CD3/CD15/CD19/CD56/CD177 (Fig. S6). The 
frequency of CD11b+/CD14+/CXCR3+ cells was higher in 
the adventitia of aneurysmal aortas than of nonaneurysmal 
aortas (Fig. 9 a). Further analysis of CD11b-selected adventi-
tial cells revealed that CXCR3 was more frequently expressed 
by macrophages characterized by a CD14+/CD16+ resident 
phenotype than by a CD14+/CD16 inflammatory pheno-
type (Fig. 9 b). The expression of the scavenger receptor 
CD163 was also greater in CD14+/CD16+ than in CD14+/
CD16 perivascular macrophages (Fig. 9 b). Finally, there 
were more numerous CD68+ macrophages resident in adven-
titia at sites of disturbed blood flow, such as the common carotid 
By immunofluorescence imaging, the induction of MMP9   
expression was only detected in the adventitia, whereas the 
up-regulation of MMP2 expression was restricted to the   
media at 3 d after outflow reduction (Fig. 6 c). In contrast, 
FXIIIA expression was expressed in both the media at baseline 
and was also associated with perivascular infiltrating cells   
(Fig. 6 c). We confirmed increased gelatinase activity as a   
result of MMP9 and MMP2 expression in remodeling arteries 
by gel and in situ zymography and increased transglutaminase 
activity within the adventitia, in addition to basal medial   
activity, after decreased blood flow (Fig. 6, d and e). The early 
accumulation of MMP9 transcripts and the later accumula-
tion of MMP2 and FXIIIA transcripts were diminished in   
common carotid arteries from the ligated side of CXCR3/ 
mice compared with WT mice (Fig. 6 f). These results do 
not exclude the possibility that the diminished expression   
of factors produced by activated macrophages was entirely   
the result of decreased monocyte recruitment and/or macro-
phage retention.
FXIIIA is selectively produced by CXCR3+  
perivascular macrophages and is frequently coexpressed 
with MMP9 in situ
To determine if CXCR3 signaling may contribute to macro-
phage activation independent of chemoattractant effects, we 
first assessed the products of different macrophage popula-
tions defined by CXCR3 expression from remodeling com-
mon carotid arteries of WT mice. The abundance of FXIIIA 
transcripts  was  significantly  higher  in  CXCR3-expressing 
CD11b-selected F4/80+ cells, and a similar trend for MMP9 
transcripts did not achieve statistical significance (Fig. 7 a).   
In contrast, TNF was detected in both CXCR3+ and CXCR3 
macrophages and MMP2 transcripts were not detected in either 
macrophage population. To examine the production of FXIIIA 
and MMP9 at the single cell level, we analyzed CD11b-selected 
CD3/B220/CD11c  perivascular  macrophages  by  immuno-
fluorescence microscopy. There was a heterogeneous expres-
sion pattern in macrophages activated with PMA/ionomycin 
ex vivo with minor populations expressing predominantly 
FXIIIA, predominantly MMP9, or neither molecule, al-
though the majority of cells displayed dual FXIIIA and 
MMP9 immunoreactivity (Fig. 7 b). These diverse macro-
phage subgroups contained both smaller cells with more 
rounded nuclei and larger cells with kidney- and horseshoe-
shaped nuclei (Fig. 7 c). Similar findings with lesser intensity 
of signal were seen in untreated adventitial macrophages 
(Fig. 7 d). These data suggested that many CXCR3-expressing 
remodeling-associated macrophages displayed both protein-
ase and transglutaminase activities.
CXCR3 signaling induces FXIIIA production by isolated 
macrophages in vitro
We next examined for direct evidence of IP-10 effects on mac-
rophages in vitro. Bone marrow monocytes were differentiated 
in culture to a macrophage-type phenotype in the presence   
of macrophage (M) CSF–conditioned medium for 7–10 d, JEM VOL. 207, August 30, 2010 
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DISCUSSION
In this study, we report several novel roles for CXCR3 in 
mouse systems: CXCR3 is necessary for flow-mediated inward 
vascular remodeling; CXCR3 is expressed by a subset of circu-
lating monocytes and perivascular macrophages with resident 
phenotypic  markers;  CXCR3  is  required  for  perivascular 
macrophage accumulation and activation after decreased blood 
flow; and CXCR3 signaling selectively induces FXIIIA   
artery bifurcation (carotid sinus), than at sites of laminar flow, 
for example, the midpoint of the common carotid artery 
(26.5 ± 3.2 vs. 14.5 ± 2.0 mm3, respectively; P < 0.05) with 
a higher expression of CXCR3 (Fig. 9 c). These data confirm 
that CXCR3 is expressed by a subset of human perivascular 
macrophages and that accumulation of this cell population spa-
tially correlates with sites of disturbed hemodynamic stresses 
on the vessel wall.
Figure 8.  IP-10 induces FXIIIA expression in cultured macrophages. (a) Bone marrow monocytes were matured in culture in the presence of  
M-CSF–enriched medium for 7–10 d before treatment with IP-10 at 300 ng/ml, LPS at 10 ng/ml, or IL-4 at 10 ng/ml for various times, and FXIIIA, MMP9, and 
TNF transcripts were measured (n = 4 pooled from four independent experiments). (b) The cells were also treated with IP-10 at various concentrations. 
FXIIIA transcripts were measured by quantitative PCR (n = 3 pooled from three independent experiments) at 72 h. FXIIIA protein was assessed by immuno-
blotting of cell lysates at 96 h, purified human FXIIIA (75 kD) was included at 100 ng/ml, -actin expression was used as loading controls, and blots are 
representative of three independent experiments. Transglutaminase activity was determined in macrophage lysates after IP-10 treatment for 96 h (n = 2 
pooled from two independent experiments). (c) Quantitative PCR was also performed after treatment with single or combined proinflammatory factors at 
72 h (n = 6–8 pooled from three independent experiments). (d) FXIIIA, MMP9, and TNF transcripts were measured in macrophages from WT mice after 
treatment with IP-10, IL-4, or LPS in the presence of CXCR3 blocking antibody (Ab) at 10 µg/ml versus irrelevant isotype-matched IgG or in macrophages 
from CXCR3/ mice and compared with that of WT mice (n = 6–12 pooled from three independent experiments). Data are means ± SE. *, P < 0.05;  
**, P < 0.001, treated versus untreated, or single versus combined treatment.1960 Role of CXCR3 in adaptive vascular remodeling | Zhou et al.
In our previous study, we found two dis-
tinct roles for MyD88 in flow-mediated inward 
vascular remodeling (Tang et al., 2008). It was 
required both for ROS-initiated vascular cell 
inflammatory responses and consequent macro-
phage accumulation and for activation of mac-
rophage effectors of vascular remodeling. We 
did not define inflammatory or remodeling   
mediators with nonredundant roles in this ini-
tial work. In our present study, we find that 
CXCR3 is necessary for perivascular macro-
phage recruitment in response to blood flow 
reduction and that IP-10 induces FXIIIA ex-
pression. The two studies are related in both 
phases  of  inward  vascular  remodeling.  First, 
MyD88-dependent vascular cell inflammatory re-
sponses are required for the production of CXCR3 
ligands.  Second,  both  MyD88-dependent  and 
CXCR3 signaling are required for production 
of macrophage mediators of vascular remodel-
ing. The MyD88-dependent effectors of vascu-
lar remodeling are as yet undefined. FXIIIA is 
identified as a CXCR3-dependent macrophage 
product that is not induced by ligands that sig-
nal through MyD88, although it has not been 
proven to play an essential role in our model.
Although we have previously described the 
production of IP-10 and Mig during flow- 
mediated inward vascular remodeling, it was sur-
prising to find a nonredundant role for their receptor CXCR3, 
as we had also found that this process is largely independent of 
T cells and only minimally reduced in RAG1/ mice (Tang 
et al., 2008). CXCR3 is known to play an essential role in inti-
mal remodeling in hypercholesterolemic mice (van Wanrooij   
et al., 2005, 2008; Veillard et al., 2005) and after wire-mediated 
injury of the mouse femoral artery (Schwarz et al., 2009). 
expression by monocytes and macrophages. We also find that 
CXCR3-expressing human macrophages of resident phenotype 
accumulate at sites of disturbed blood flow. These findings pro-
vide new insights into the mechanisms of macrophage-mediated 
vascular remodeling in response to hemodynamic forces and 
suggest that a unique macrophage phenotype is involved in   
homeostatic responses triggered by tissue stress.
Figure 9.  Human perivascular macrophages express 
CXCR3. (a) CD11b+ cells were isolated from blood or 
aortic adventitia using magnetic beads, analyzed by flow 
cytometry for control IgG reactivity or CD14 and CXCR3 
expression, and a representative dot plot and combined 
results (n = 4) are shown. CXCR3 expression by perivas-
cular macrophages was also compared between the non-
aneurysmal (n = 5) and aneurysmal aortas (n = 3).  
(b) CD11b+/CD14+ adventitial cells were further analyzed 
for the CD16 resident macrophage marker in addition to 
CXCR3 and CD163 expression, and a representative dot 
plot and combined results (n = 7) are shown. (c) Distal 
(sinus) and mid-common carotid arteries (n = 3) were 
analyzed for CD68 (green) and CXCR3 (red) expression by 
immunofluorescence, and the frequency of CXCR3+/
CD68+ cells (double-positive cells marked by arrowheads) 
were expressed as the percentage of total CD68+ cells. 
Bar, 25 µm. Data are means ± SE (each replicate is de-
rived from a different donor and each specimen was 
processed independently). *, P < 0.05.JEM VOL. 207, August 30, 2010 
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T cells. More direct evidence of CXCR3-mediated effects 
includes chemotaxis of purified populations of human mono-
cytes in response to IP-10 in vitro (Taub et al., 1993, 1996; 
Kohrgruber et al., 2004). We extend these observations by 
demonstrating  a  physiological  role  for  CXCR3-mediated 
macrophage accumulation in adaptive vascular remodeling 
and show that IP-10 recruits monocytes to the arterial adven-
titia independent of lymphocytes in RAG1/ mice.
Circulating monocytes and tissue macrophages, including 
those present in blood vessels, are characterized as long-lived 
resident cells or short-lived inflammatory cells with distinct 
migratory patterns (Geissmann et al., 2003). Resident mac-
rophages have been described in the aortic adventitia of 
normocholesterolemic  mice  (Galkina  et  al.,  2006),  and 
macrophage-derived foam cells in developing atherosclerotic 
lesions do not derive from resident adventitial macrophages 
(Lessner et al., 2002). However, Gr1low resident monocytes 
that patrol the resting vasculature can rapidly invade the 
vessel wall in response to inflammatory signals (Auffray et al., 
2007). We have not determined the origin of macrophages 
accumulating in remodeling arteries, a subject of future stud-
ies, although a 65-fold increase in cell number within 3 d of 
altered hemodynamic stresses (Tang et al., 2008) makes it 
unlikely that they are all derived from preexisting resident 
macrophages and suggests that the influx of cells mostly   
accrue from the circulation. Inflammatory macrophages, in-
cluding those within atherosclerotic arteries, are described as 
Gr1high (Geissmann et al., 2003; Tacke et al., 2007), although 
it is known that the expression of Ly-6C decreases as mono-
cytes remain in the circulation (Sunderkötter et al., 2004)   
and  that  adoptively  transferred  monocytes  down-regulate 
Ly-6C expression after entering atherosclerotic aortic plaques 
(Swirski et al., 2007). Thus, Gr1low macrophages in the adven-
titia of remodeling arteries may be derived from circulating 
Gr1high cells that subsequently decreased the expression of this 
marker or, alternatively, may be selectively derived from cir-
culating Gr1low cells. Our findings of smaller and larger perivas-
cular macrophages are similar to previous descriptions of blood 
and spleen monocytes in which size and nuclei shape defined 
different cell differentiation states (Swirski et al., 2009).
In addition to its chemotactic effects, CXCR3 signaling 
is also known to play a role in the proliferation, effector cyto-
kine production, and reactive oxygen species generation of   
T cells (Whiting et al., 2004; Schwarz et al., 2009). However, 
CXCR3 has not been described to contribute to macrophage 
activation. The differences in expression of macrophage me-
diators of inflammation and remodeling between WT and 
CXCR3/ mice in our study may be entirely the result of 
differences in cell numbers, although the differential gene ex-
pression between CXCR3+ and CXCR3 perivascular mac-
rophages in WT mice and the effects of IP-10 on isolated 
monocytes and macrophages argue against this interpretation. 
We show induction of FXIIIA expression by IP-10 treatment 
in addition to the up-regulation of this molecule by M-CSF–
dependent differentiation of mouse bone marrow–derived 
macrophages. LPS and IL-4 inhibit these responses, and the 
However, the function of CXCR3 in these models of neo-
intima formation is as a chemoattractant for T cells. Specifi-
cally, monocyte recruitment to atherosclerotic plaques is not 
reduced in hypercholesterolemic animals with genetic defi-
ciency or pharmacologic inhibition of CXCR3 (van Wanrooij 
et al., 2005, 2008; Veillard et al., 2005). This discrepancy with 
our findings may reflect different homing requirements or re-
tention signals for adventitial versus intimal compartments under 
physiological and pathological settings, respectively. Leukocyte–
endothelial interactions are dependent on hemodynamic fac-
tors and the endothelial phenotype, which differ between 
adventitial  microvessels  and  the  lumen  of  conduit  arteries 
(Langheinrich et al., 2007). Temporal and spatial variables 
may also play a role. Notably, the perivascular inflammation in 
response to altered shear stress in our model is transient and 
resolves without neointima formation after the adaptive changes 
in vessel size have occurred within 1–2 wk (Tang et al., 2008). 
The interpretation of our adoptive transfer experiments in 
which WT monocytes rescued the inward vascular remodel-
ing phenotype in CXCR3/ mice is limited by the caveats 
that negatively selected bone marrow myeloid cells may contain 
rare nonmonocyte precursor cells with sufficient proliferation 
potential to influence the results, small numbers of contaminat-
ing granulocytes that do not express CXCR3 may have non-
redundant effects, and the initial perivascular accumulation of 
relatively few WT macrophages may secondarily recruit 
CXCR3/ cells thus playing a critical but not sufficient role.
We document variable expression of CXCR3 by mouse 
CD11b+ F4/80+ cells from different anatomical sites. Robust 
expression of CXCR3 was previously reported for mouse 
thioglycollate-elicited peritoneal macrophages (Janatpour   
et al., 2001). In contrast, CXCR3 was undetectable in many 
analyses of human monocytes and macrophages (Janatpour   
et al., 2001; Katschke et al., 2001; Geissmann et al., 2003; 
Cho et al., 2007). We confirm that human circulating mono-
cytes do not express CXCR3, but we demonstrate that peri-
vascular macrophages, particularly of cells characterized by a 
CD14+/CD16+ resident phenotype (Geissmann et al., 2003), 
selectively express CXCR3 in addition to the scavenger re-
ceptor CD163 (Kim et al., 2006). Tissue macrophages that 
coexpress CD163 and FXIIIA have been described in human 
skin (Zaba et al., 2007). Because unstimulated human mono-
cytes, unlike mouse myeloid cells, do not express detectable 
CXCR3, signaling by this receptor may recruit rare circulat-
ing precursors or contribute to the retention and activation of 
differentiated human tissue macrophages at sites of disturbed 
hemodynamic stresses. IP-10 elicits mouse monocyte recruit-
ment in vivo (Luster and Leder, 1993; Taub et al., 1993, 
1996), and deficient CXCR3 signaling is associated with di-
minished  accumulation  of  macrophages  in  various  mouse 
models  of  inflammation  (Hancock  et  al.,  2000;  Janatpour   
et al., 2001; Waeckel et al., 2005; Heller et al., 2006; van 
Wanrooij et al., 2008). However, the interpretation of these 
findings is limited without confirmation of CXCR3 expres-
sion by the recruited macrophages and by not excluding in-
direct effects on monocyte trafficking by CXCR3-expressing 1962 Role of CXCR3 in adaptive vascular remodeling | Zhou et al.
nonredundant roles for TNF and iNOS in flow-mediated 
inward vascular remodeling is surprising given their essen-
tial functions in arterial remodeling in models of hyper-
tension  and  graft  arteriosclerosis,  respectively,  although 
these  inflammatory  mediators  were  described  as  T  cell 
products in these studies (Koh et al., 2004; Guzik et al., 
2007). Given its role in vascular smooth muscle cell pro-
liferation (Selzman et al., 1999), one may speculate that 
the persistence of TNF production in CXCR3/ animals 
in this study and in MyD88/ animals or in monocyte-
depleted animals in our previous study (Tang et al., 2008) 
may be responsible for the paradoxical medial thickening 
observed in the absence of inward vascular remodeling. 
We have not investigated if the artery-associated macro-
phages in our in vivo model are polarized into mutually 
exclusive subsets or whether single cells retain plasticity to 
secrete both M1 and M2 products. Recent work on het-
erogeneous macrophage subsets involved in tissue healing 
and remodeling after myocardial infarction showed both 
MMP activity and TNF production by all Ly-6Chigh mac-
rophages  using  single  event  histograms,  suggesting  dual 
production of M1 and M2 products in vivo (Nahrendorf 
et al., 2007). The paradigm of macrophage polarization 
requires further confirmation using multiple event histo-
gram analysis of intracellular products by flow cytometry 
as commonly performed in studies of T cell differentiation.
An additional point emphasized by the present study is 
that macrophages have important homeostatic roles in addi-
tion to those of host defense. The essential function of mac-
rophages in conduit artery remodeling in response to altered 
hemodynamic stresses is an example of the former (Bakker   
et al., 2008; Tang et al., 2008; Nuki et al., 2009). The inflam-
matory component of flow-mediated vascular remodeling is 
remarkably well orchestrated, such that adaptive changes in 
vessel size occur without apparent pathological sequelae. Dif-
ferent initiators of inflammation, namely tissue stress, tissue 
injury, and infection, elicit markedly different responses of 
homeostasis, tissue repair, and host defense, respectively. This 
suggests that different types of inflammation use distinct com-
binations of sensors, mediators, and effectors. It has been pro-
posed that inflammation triggered by tissue stress be referred 
to as parainflammation to distinguish the process as an inter-
mediate between the basal homeostatic state and classical   
inflammation triggered by pathogen-associated or damage-
associated molecular patterns (Medzhitov, 2008). Because all 
forms of inflammation may have pathological consequences 
if unproductive and persistent, it is important to understand 
their underlying mechanisms. Indeed, it has been hypothe-
sized  that  dysregulated  parainflammation  caused  by  tissue 
malfunction may underlie many chronic illnesses (Medzhitov, 
2008). However, relatively little is known about inflamma-
tory responses to tissue stress. We find that, unlike Gr1high 
monocyte homing to the intima of atherosclerotic arteries 
known  to  be  CXCR3  independent,  Gr1low  macrophage   
accumulation and function in the adventitia of remodeling 
arteries is CXCR3 dependent.
cross-regulation of effector molecules by different macro-
phage  activators  is  well  established  (Mosser  and  Edwards, 
2008). IP-10 is strongly induced in macrophages by IFN- so 
that FXIIIA induction could arise from autocrine or para-
crine signaling in M1 type activation. Alternatively, the char-
acteristics of CXCR3-mediated macrophage activation may 
be  considered  to  be  partial  M2  polarization  even  though 
there are striking differences with the phenotype induced by 
the prototypical alternative activator IL-4 in mouse macro-
phages, as it recapitulates IL-4–mediated induction of FXIIIA 
in  human  macrophages  (Gratchev  et  al.,  2005;  Töröcsik   
et al., 2005; Martinez et al., 2008). The limited but unique 
pattern of macrophage activation by CXCR3 ligands, which 
is not seen with IL-4 or LPS, suggests a role for a macrophage 
population in the arterial wall that is neither M1 nor M2 and 
is responsible for adaptive vascular remodeling. M1- and   
M2-independent effects of another chemokine, PF4/CXCL4 
(which shares binding sites with IP-10), have recently been 
described as M4 activation of blood-derived macrophages 
(Gleissner et al., 2010). Although the IP-10–dependent in-
duction of FXIIIA in cultured macrophages was only several-
fold, it was similar in magnitude to that in remodeling arteries. 
In a previous microarray study of human blood-derived mac-
rophages, modest differences in gene expression were found 
in response to relatively high doses of MCP-1/CCL2 and 
GRO-/CXCL1  without  obvious  polarization  signatures 
(Cho et al., 2007). In vitro studies require comparatively high 
concentrations of IP-10 or other chemokines as a result of 
lower affinities for their cognate receptors than those of many 
proinflammatory cytokines. High local concentrations of   
IP-10 may be reached in vivo by binding to low-affinity 
nonspecific binding sites on surface proteoglycans, such as on 
endothelial cells (Ranjbaran et al., 2006). The activation of 
monocytes and macrophages by chemokines may also be de-
pendent on their state of differentiation, and M-CSF has a 
significant  transcriptional  program  (Martinez  et  al.,  2006, 
Cho et al., 2007). The ability of CXCR3 ligands to both re-
cruit and activate macrophages (this study) and to both re-
cruit and activate lymphocytes (Whiting et al., 2004; Schwarz 
et al., 2009) qualifies these inflammatory mediators as alarm-
ins or immune amplifiers (Oppenheim and Yang, 2005).
The production of diverse macrophage-derived factors 
are found in remodeling arteries, including products of 
M1 polarized macrophages, such as iNOS and TNF, and 
products of M2 polarized macrophages, such as MMP9 
and FXIIIA (Galis et al., 2002; Bakker et al., 2006, 2008; 
Tang et al., 2008; Nuki et al., 2009). Indeed, TNF, IL-4, 
and TGF- are all expressed in remodeling arteries after 
reduction of blood flow (Bakker et al., 2008) and may 
trigger classical activation, alternative activation, and de-
activation of macrophages, respectively. Smooth muscle 
cell death, in addition to extracellular matrix degradation 
and cross-linking, occurs in inward vascular remodeling 
(Rudic et al., 2000; Tang et al., 2008) and, thus, the activ-
ity of both cytotoxic (M1) and tissue repair (M2) mac-
rophages  may  be  expected  to  play  a  role.  The  lack  of JEM VOL. 207, August 30, 2010 
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were collected from 4–20 mice, red blood cells were lysed with ACK buffer 
(Bio Whittaker), and mononuclear cells were enriched by Lymphocyte   
Separation Medium (MP Biomedicals). For phenotyping experiments and 
adoptive  transfer  experiments  with  circulating  cells,  CD11b+  monocytes 
were positively isolated with antibody-coated magnetic beads and MACS LS 
cell separation columns (Miltenyi Biotec). Alternatively, for adoptive transfer 
experiments with bone marrow cells, CD11b+ myeloid cells were negatively 
selected by incubation with magnetic beads coated with antibodies to CD90 
(T cell marker), B220 (B cell marker), DX5 (natural killer cell marker), and 
TER-119 (red blood cell marker), passage through MACS LS cell separation 
columns, and collection of the filtrate. 106 blood monocytes or 2.7 × 106 
bone marrow myeloid cells were injected i.v. 12 h before left external ca-
rotid artery ligation.
For experiments with in vitro differentiated macrophages, unselected 
bone marrow cells were cultured in DME containing 10% FBS, 10% L929 
cell–conditioned medium (enriched for M-CSF), 2 mM L-glutamine, 100 
units/ml penicillin, and 100 µg/ml streptomycin (Invitrogen). Adherent cells 
were harvested after 7–10 d with a rubber scraper, resuspended in M-CSF–
enriched and complete DME medium and treated with IP-10, LPS, and/or 
IL-4. FXIIIA-depleted FBS was used for analyses of FXIIIA protein expres-
sion and transglutaminase activity.
For isolation of artery-associated macrophages, common carotid arteries 
were pooled from 18–22 mice and digested with 125 U/ml collagenase XI, 
60 U/ml hyaluronidase I, 60 U/ml DNase 1, and 450 U/ml collagenase I 
(Sigma-Aldrich) in phosphate-buffered saline containing 20 mM Hepes at 
37°C for 1–2 h. The tissue pieces and supernatant were resuspended in 
RPMI-1640 medium at 4°C and sequentially passed through 0.5- and 0.1-mm   
sieves. Macrophages were isolated with CD11b antibody-coated magnetic 
beads and cell separation columns, and the selected cells were >95% CD11b+. 
In certain experiments, the cells were further selected by flow cytometric 
sorting as indicated. For isolation of human macrophages, similar techniques 
were used as for mouse cells, except that enzymatic digestion of the aortic 
adventitia was for 2–4 h.
Quantitative PCR. Total RNA was isolated and DNase treated using the 
NanoPrep system (Agilent Technologies). Bulk reverse transcription was 
performed using random hexamer primers according to the MultiScribe RT 
system protocol (Applied Biosystems). Real-time RT-PCR reactions were 
performed in duplicate using Taqman PCR reagents and Taqman gene ex-
pression probes for GAPDH, IP-10, Mig, TNF, iNOS, F4/80, CXCR3, 
MMP2,  MMP9,  FXIIIA,  Arginase  I,  Ym1,  Fizz1,  IL-10,  and  TGM2   
(Applied Biosystems). DNase-treated RNA samples produced without RT 
enzyme served as negative controls. An iCycler and its system interface soft-
ware (Bio-Rad Laboratories) were used to analyze the samples and data. 
Transcript expression levels were normalized to GAPDH.
Cytospins. Artery-associated macrophages were either immediately col-
lected or treated with PMA at 500 ng/ml and ionomycin at 50 ng/ml 
(Sigma-Aldrich) in the presence of brefeldin A (BD) for 5 h. The cells 
were pelleted onto slides at 800 rpm for 10 min, air dried for 30 min, and 
fixed with 4% paraformaldehyde for 20 min. Before immunostaining, the 
cells were permeabilized with 0.1% Triton X-100 for 30 min and then 
blocked with 2% BSA for 1 h. The labeled slides were examined by fluo-
rescence microscopy and the signal was quantified within the outline of 
individual cells as the percentage of area using image analysis software 
(ImageJ). Cells were considered positive for FXIIIA or MMP9 expression 
if FITC or TRITC signal exceeded 5% of cell area, respectively, and 
were classified as null, predominantly FXIIIA, predominantly MMP9, or 
dual expressors.
Western blotting. Cell lysates were prepared in RIPA buffer and boiled   
in SDS sample buffer for 10 min. An equal volume of samples was loaded,   
and proteins were separated by SDS-PAGE, transferred electrophoretically to 
a nitrocellulose membrane (Bio-Rad Laboratories), and blotted with goat 
MATERIALS AND METHODS
Clinical specimens. Blood, adventitia (stripped from the thoracic aorta), 
and/or common carotid arteries (midvessel and distal sinus) were obtained 
from five organ donors and adventitia was also obtained from three patients 
undergoing thoracic aortic aneurysm repair under protocols approved by   
the Yale University Human Investigation Committee, the West Haven VA 
Hospital, and the New England Organ Bank. Demographic and clinical in-
formation of the eight individuals included the following: mean age 42.1 ± 
21.6 yr (range 5–67 yr); five males and three females; six Caucasians, one   
African-American, and one Hispanic; and four normal aortas, one athero-
sclerotic aorta, and three ascending aortic aneurysms.
Mice. C57BL/6, IL-1R/, IL-6/, iNOS/, TNFR1/, TNFR2/, 
and  RAG1/  mice  were  purchased  from  The  Jackson  Laboratory. 
CXCR3/  mice  were  obtained  from  C.  Gerard  (Harvard  University, 
Cambridge, MA) and have been previously described (Hancock et al., 2000). 
All strains had been back bred to a C57BL/6 background for >10 genera-
tions. Procedures were performed in 8–12-wk-old male mice.
Carotid artery procedures. Animal studies were approved by the Yale 
University Institutional Animal Care and Use Committee. After anesthesia, 
a midline cervical incision was performed, the left external carotid artery was 
isolated and ligated with 6–0 silk, and the wound was closed with 5–0 
prolene. After 6 h–10 d, RNA, protein, and cellular studies of the common 
carotid arteries were performed after saline perfusion of the vasculature.   
After  2  wk,  morphometry  studies  of  the  common  carotid  arteries  were   
performed after fixation-perfusion with 4% paraformaldehyde in PBS at a 
mean pressure of 100 mmHg, and then arteries were embedded in OCT 
medium. Alternatively, the tissues around the common carotid arteries of 
RAG1/ mice were infiltrated with 30 µl nonpyrogenic saline or mouse 
IP-10 at 300 ng/µl (PeproTech) and the vessels were procured after 3 d for 
immunohistochemical analysis.
Morphometry. Hematoxylin and eosin–stained sections of the mid-common 
carotid arteries were analyzed by microscopy. Internal and external elastic 
lamina perimeters, as well as medial thickness at four quadrants, were mea-
sured and averaged over 10 separate sections using an image software pro-
gram (ImageJ; National Institutes of Health).
Immunohistochemistry.  Primary  antibodies  included  rat  anti–mouse 
CXCR3 (R&D Systems), rat anti–mouse F4/80 (Abcam), and rabbit anti–
mouse IP-10 (AbD Serotec). Isotype-matched nonbinding immunoglobulin 
was used as negative control. Binding of secondary antibodies (Jackson Im-
munoResearch Laboratories) was detected with Vectastain ABC reagent and 
AEC peroxidase substrate kits (Vector Laboratories). Sections were counter-
stained with hematoxylin (Sigma-Aldrich). Nuclei surrounded by positive 
immunostaining were enumerated at high magnification.
Immunofluorescence analysis. Primary antibodies for tissue sections in-
cluded FITC-conjugated rat anti–mouse F4/80 (eBioscience), rabbit anti–
mouse CXCR3 (MLB International), rabbit anti–mouse MMP2 (Millipore), 
goat  anti–mouse  MMP9  (R&D  Systems),  and  goat  anti–human  FXIIIA   
(sc-18013, cross-reactive with mouse FXIIIA; Santa Cruz Biotechnology, 
Inc.). For analysis of human arteries, rabbit anti–human CD68 (Santa Cruz 
Biotechnology,  Inc.)  and  mouse  anti–human  CXCR3  (BD)  were  used.   
Primary  antibodies  for  cytospin  preparations  included  rabbit  anti–mouse 
MMP9 (Abnova) and goat anti–human FXIIIA. Isotype-matched nonbind-
ing immunoglobulin was used as negative control. Detection of nonconju-
gated primary antibodies was visualized with secondary antibodies conjugated 
with FITC, TRITC (Jackson ImmunoResearch Laboratories), PE (Invitrogen), 
Alexa Fluor 594, or Alexa Fluor 488 (Invitrogen). Sections were counter-
stained with DAPI (Invitrogen).
Monocyte  and  macrophage  isolation. Blood, single cell suspensions 
from minced spleens, and bone marrow cells from bilateral femurs and tibias 1964 Role of CXCR3 in adaptive vascular remodeling | Zhou et al.
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